Longzang Biotech and Jinyao Daren Tang Forge Strategic Alliance to Unlock New Pathways in Traditional Chinese Medicine Health Industry Using Plant Stem Cell Technology

The traditional Chinese herbal medicine industry has long been plagued by core challenges, including significant quality fluctuations, unstable production capacity, and a lack of standardization. Particularly in the cultivation of rare medicinal herbs, issues such as pesticide residues, excessive heavy metal levels, and difficulties in controlling active ingredients have severely constrained industry development. Today, plant stem cell technology offers a critical pathway to resolving these predicaments through industrialized and precision-based production models.

Recently, Changzhou Longzang Biotechnology Co., Ltd. (“Longzang Biotech”) and Tianjin Pharmaceutical Darentang Group Co., Ltd. (“Tianjin Pharma Darentang”) have entered into a strategic partnership to officially launch multi-dimensional product development in the fields of pharmaceuticals, food, and cosmetics based on plant stem cell technology.

Traditional Chinese medicinal materials heavily rely on natural growth environments, leading to significant fluctuations in active ingredients and the gradual depletion of rare resources. To address these challenges, Longcang Biology, whose core team comprises experts in plant genomics, molecular biology, and plant metabolomics, has proposed a composite technological system of “medicinal plant cell culture + purified CMC stem cells.” This approach leverages its proprietary core technologies in stem cell cultivation and plant-derived exosome preparation. By employing cell culture techniques, this system significantly enhances the controllability and consistency of active ingredients, fundamentally transforming the instability inherent in traditional Chinese medicinal material production that is subject to environmental uncertainties.

Tianjin Pharmaceutical Darentang is an A+H share listed company controlled by Tianjin Pharmaceutical Group. With green traditional Chinese medicine (TCM) as its core, it covers the entire industry chain, including herbal cultivation, research and development, production, distribution, and general health. The company owns time-honored brands such as Darentang, Longshunrong, Leren Tang, and Jingwanhong, holds six China Well-Known Trademarks including “Darentang,” and features core products such as Suxiao Jiuxin Wan (Quick-Acting Heart-Saving Pills), Qingyan Diwan (Throat-Clearing Dropping Pills), and Biqi Capsules. As a leader in modern TCM, Tianjin Pharmaceutical Darentang is the cradle of modern TCM formulation technology in China and has pioneered the research and development of many new TCM dosage forms in the People's Republic of China.

Longzang Biology, established in 2018, is a biotechnology enterprise focused on technological innovation in plant stem cells. Its core team spans multiple disciplines and has achieved breakthroughs in the industrial-scale cultivation of various medicinal plant species, providing technical support to address industry challenges such as the lack of standardization in traditional Chinese medicine and the depletion of rare medicinal plant resources.

The two parties will collaborate closely around the core strategic direction of Jingyao Darentang, leveraging Longzang Biology’s cell culture technology and Jingyao Darentang’s expertise in the industrialization of traditional Chinese medicine to develop innovative solutions for the health management industry.

“Longzang Bio’s technology has achieved key breakthroughs in the cultivation of medicinal plant stem cells and the enrichment of active ingredients across multiple categories. By leveraging Tianjin Pharma Darentang’s mature industrialization system and channel resources, both parties are poised to open new growth pathways in the broader health sector, including functional foods and innovative traditional Chinese medicine (TCM) drugs, thereby setting a benchmark for the high-value transformation of traditional medicinal materials,” said the head of Longzang Bio.